273 related articles for article (PubMed ID: 35218154)
1. A B-cell or a key player? The different roles of B-cells and antibodies in melanoma.
Rodgers CB; Mustard CJ; McLean RT; Hutchison S; Pritchard AL
Pigment Cell Melanoma Res; 2022 May; 35(3):303-319. PubMed ID: 35218154
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma.
Lynch KT; Young SJ; Meneveau MO; Wages NA; Engelhard VH; Slingluff CL; Mauldin IS
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34103353
[TBL] [Abstract][Full Text] [Related]
3. Tertiary lymphoid structures in desmoplastic melanoma have increased lymphocyte density, lymphocyte proliferation, and immune cross talk with tumor when compared to non-desmoplastic melanomas.
Edmonds NL; Gradecki SE; Katyal P; Lynch KT; Stowman AM; Gru AA; Engelhard VH; Slingluff CL; Mauldin IS
Oncoimmunology; 2023; 12(1):2164476. PubMed ID: 36632563
[TBL] [Abstract][Full Text] [Related]
4. B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies.
Willsmore ZN; Harris RJ; Crescioli S; Hussein K; Kakkassery H; Thapa D; Cheung A; Chauhan J; Bax HJ; Chenoweth A; Laddach R; Osborn G; McCraw A; Hoffmann RM; Nakamura M; Geh JL; MacKenzie-Ross A; Healy C; Tsoka S; Spicer JF; Papa S; Barber L; Lacy KE; Karagiannis SN
Front Immunol; 2020; 11():622442. PubMed ID: 33569063
[TBL] [Abstract][Full Text] [Related]
5. Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application.
Zhang Y; Xu M; Ren Y; Ba Y; Liu S; Zuo A; Xu H; Weng S; Han X; Liu Z
Mol Cancer; 2024 Apr; 23(1):75. PubMed ID: 38582847
[TBL] [Abstract][Full Text] [Related]
6. Tertiary lymphoid structures improve immunotherapy and survival in melanoma.
Cabrita R; Lauss M; Sanna A; Donia M; Skaarup Larsen M; Mitra S; Johansson I; Phung B; Harbst K; Vallon-Christersson J; van Schoiack A; Lövgren K; Warren S; Jirström K; Olsson H; Pietras K; Ingvar C; Isaksson K; Schadendorf D; Schmidt H; Bastholt L; Carneiro A; Wargo JA; Svane IM; Jönsson G
Nature; 2020 Jan; 577(7791):561-565. PubMed ID: 31942071
[TBL] [Abstract][Full Text] [Related]
7. Tertiary lymphoid structures and associated plasma cells play an important role in the biology of triple-negative breast cancers.
Seow DYB; Yeong JPS; Lim JX; Chia N; Lim JCT; Ong CCH; Tan PH; Iqbal J
Breast Cancer Res Treat; 2020 Apr; 180(2):369-377. PubMed ID: 32034580
[TBL] [Abstract][Full Text] [Related]
8. B cells and tertiary lymphoid structures promote immunotherapy response.
Helmink BA; Reddy SM; Gao J; Zhang S; Basar R; Thakur R; Yizhak K; Sade-Feldman M; Blando J; Han G; Gopalakrishnan V; Xi Y; Zhao H; Amaria RN; Tawbi HA; Cogdill AP; Liu W; LeBleu VS; Kugeratski FG; Patel S; Davies MA; Hwu P; Lee JE; Gershenwald JE; Lucci A; Arora R; Woodman S; Keung EZ; Gaudreau PO; Reuben A; Spencer CN; Burton EM; Haydu LE; Lazar AJ; Zapassodi R; Hudgens CW; Ledesma DA; Ong S; Bailey M; Warren S; Rao D; Krijgsman O; Rozeman EA; Peeper D; Blank CU; Schumacher TN; Butterfield LH; Zelazowska MA; McBride KM; Kalluri R; Allison J; Petitprez F; Fridman WH; Sautès-Fridman C; Hacohen N; Rezvani K; Sharma P; Tetzlaff MT; Wang L; Wargo JA
Nature; 2020 Jan; 577(7791):549-555. PubMed ID: 31942075
[TBL] [Abstract][Full Text] [Related]
9. B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome.
Fridman WH; Meylan M; Petitprez F; Sun CM; Italiano A; Sautès-Fridman C
Nat Rev Clin Oncol; 2022 Jul; 19(7):441-457. PubMed ID: 35365796
[TBL] [Abstract][Full Text] [Related]
10. Tertiary Lymphoid Structures: Autoimmunity Goes Local.
Pipi E; Nayar S; Gardner DH; Colafrancesco S; Smith C; Barone F
Front Immunol; 2018; 9():1952. PubMed ID: 30258435
[TBL] [Abstract][Full Text] [Related]
11. Participation of B cell in immunotherapy of cancer.
Chandnani N; Gupta I; Mandal A; Sarkar K
Pathol Res Pract; 2024 Mar; 255():155169. PubMed ID: 38330617
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation.
Salem D; Chelvanambi M; Storkus WJ; Fecek RJ
Front Immunol; 2021; 12():629519. PubMed ID: 33746966
[TBL] [Abstract][Full Text] [Related]
13. Identification and Characterization of Tertiary Lymphoid Structures in Murine Melanoma.
Rodriguez AB; Peske JD; Engelhard VH
Methods Mol Biol; 2018; 1845():241-257. PubMed ID: 30141017
[TBL] [Abstract][Full Text] [Related]
14. Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy.
Groeneveld CS; Fontugne J; Cabel L; Bernard-Pierrot I; Radvanyi F; Allory Y; de Reyniès A
Eur J Cancer; 2021 May; 148():181-189. PubMed ID: 33743486
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory B cells correlate with failure to checkpoint blockade in melanoma patients.
de Jonge K; Tillé L; Lourenco J; Maby-El Hajjami H; Nassiri S; Racle J; Gfeller D; Delorenzi M; Verdeil G; Baumgaertner P; Speiser DE
Oncoimmunology; 2021 Feb; 10(1):1873585. PubMed ID: 33643691
[TBL] [Abstract][Full Text] [Related]
16. Multiplex Immunofluorescence Histology for Immune Cell Infiltrates in Melanoma-Associated Tertiary Lymphoid Structures.
Mauldin IS; Mahmutovic A; Young SJ; Slingluff CL
Methods Mol Biol; 2021; 2265():573-587. PubMed ID: 33704741
[TBL] [Abstract][Full Text] [Related]
17. Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.
Liu X; Tsang JYS; Hlaing T; Hu J; Ni YB; Chan SK; Cheung SY; Tse GM
Oncologist; 2017 Nov; 22(11):1316-1324. PubMed ID: 28701569
[TBL] [Abstract][Full Text] [Related]
18. Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?
Siliņa K; Rulle U; Kalniņa Z; Linē A
Cancer Immunol Immunother; 2014 Jul; 63(7):643-62. PubMed ID: 24695950
[TBL] [Abstract][Full Text] [Related]
19. Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies.
Trüb M; Zippelius A
Front Immunol; 2021; 12():674565. PubMed ID: 34054861
[TBL] [Abstract][Full Text] [Related]
20. Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies.
N J; J T; Sl N; Gt B
Oncoimmunology; 2021 Mar; 10(1):1900508. PubMed ID: 33854820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
